News
CHICAGO — Compounded oral liquid levothyroxine products vary in stability, potency and consistency and present risks for patients, according to data presented the American Thyroid Association ...
You have full access to this article via your institution. These results have led the Endocrine Society, the American Association of Clinical Endocrinologists, and the American Thyroid Association ...
Additionally, this review highlights the importance of evaluating the risk-benefit ratio of levothyroxine therapy, particularly in the setting of TSH suppression, focusing on its effects on quality of ...
Background Subclinical hypothyroidism (SCH) has been associated with increased carotid intima-media thickness (C-IMT) in recent studies, but the effects of levothyroxine (L-T4) therapy on C-IMT in SCH ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results